The Pulmonary Fibrosis Foundation (PFF) has launched “PF Basics: Info for Newly Diagnosed Patients,” a new educational program to help patients with pulmonary fibrosis (PF) and interstitial lung ...
CAL101, an investigational therapy with the potential to treat pulmonary fibrosis, showed a favorable safety and pharmacological profile in a Phase 1 clinical trial, according to results announced by ...
How is it already November? Here in the U.S., today is Election Day, so get out and vote if you haven’t already done so. I wanted to take the opportunity this week to update you on topics I’ve ...
Watching the U.S. elections last week was an exercise in mental health awareness, as is any activity in which the outcome is greeted with mixed reactions and emotions. The refrain from Carly Simon’s ...
MNKD-201, Mannkind’s inhaled formulation of nintedanib for treating idiopathic pulmonary fibrosis (IPF), was found to be safe and well tolerated in a Phase 1 clinical trial involving healthy ...